Epstein Secrets

tin, should we try to touch base on Monday? The rest of the week is pretty much shot for me with visitors. Best, Don > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. < > Don , Jeffrey > wrote: EFTA00636423 > I would like to put you in direct email contact. > also cc Lesley. >m please note The i

r you around on the weekend in cambridge.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin < wrote: OK. I'll get back to you after I make contact with Adriaan again, and my plans settle a bit. On Dec 7, 2016, at 10:38 AM, jeffrey E. <jeevacation®gmail.com> wrote: three way skype for 3. and yes 1 face to f

effects is the following. This morning I just had an exchange of emails with the CEO of EB, whom I've known and worked with for about three years, Adriaan Tuiten. He wrote that FDA has agreed with EB's proposal for more trials, and the EB board of directors just approved the issuance of about 12 million Euros

nday?1> The rest of the week is pretty much shot for me with visitors. Best, Don 3 EFTA_R1_01918722 EFTA02667103 > On D=c 2, 2016, at 9:32 AM, Nowak, Martin A. <mailto: wrote: > Don , Jeffrey > I would like to put you in direct email contact. <=r>> > also cc Lesley. &g=; =br class="m_-4784

around =n the weekend in cambridge.? =br> On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin= wrote: OK. I'll get back to you=after I make contact with Adriaan again, and my plans settle a bit. <=iv> On Dec=7, 2016, at 10:38 AM, jeffrey E. <[email protected] <mailto:[email protected]=m> wrote: =div

effects is the following. This morni=g I just had an exchange of emails with the CEO of EB, whom I've k=own and worked with for about three years, Adriaan Tuiten. He wrote =hat FDA has agreed with EB's proposal for more trials, and the EB =oard of directors just approved the issuance of about 12 million Euros

8783 EFTA02667150 > On Dec 2, =016, at 9:32 AM Nowak Martin A <mai > wrote:=br class="m 119680578881

ar you around on the weekend in cambridg=.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin wrote: OK. I'll get back to you after I make contact with=Adriaan again, and my plans settle a bit. wrote: wrote: On Dec 7, 2016, at 10:38 AM, jef=rey E. <[email protected] <mailto:[email protected]» thr

eff=cts is the following. This morning I just had an exchange of emails =ith the CEO of EB, whom I've known and worked with for about three=years, Adriaan Tuiten. He wrote that FDA has agreed with EB'= proposal for more trials, and the EB board of directors just approved the=issuance of about 12 million Euros

? =he rest of the week is pretty much shot for me with visitors. 2 EFTA_R1_01919123 EFTA02667399 Best, Don =br> > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. «= href="mailto class="m_-1196805788815373682g=ail_msg" target="_blank" wrote: > Don , Jeffrey > I w=uld like to put you in direct ema

topic of placebo respon=e, which are still not that wonderfully written. =. If interested in exploring investing in EB, I can put you in touch=with Adriaan, who lives in Amsterdam. Are any of =hese appealing? I prefer 1 to 2. I think a face to face versio= of 3 could be arranged either here or there. l

o effects is the following. This morning I just had an =xchange of emails with the CEO of EB, whom I've known and worked w=th for about three years, Adriaan Tuiten. He wrote that FDA has agre=d with EB's proposal for more trials, and the EB board of director= just approved the issuance of about 12 million Euro

From: jeffrey E. <[email protected]> Sent: Friday, December 9, 2016 11:21 AM To: Donald Rubin; Nowak, Martin Subject: Re: pitch-deck 5 better On Fri, Dec 9, 2016 at 7:20 AM, Donald Rubin < > wrote: Martin's at 7 - 7:30? <=iv> wrote: On Dec 9

To: "jeff=ey E." «mailto:[email protected]» Cc: Adriaan Tuiten Hi Jeffrey, EFTA_R1_01919501 EFTA02667640 </=iv> Just got off the call with Adriaan. Attached is the Q=9Cpitch deck" for EB. I'll try for a three- way skype=call on Monday morning, our time. I hope to have details for the cal= before

warded messa e From: Donald Rubin Date= Thu, Dec 8, 2016 at 8:56 AM Subject: Fwd: pitch-deck To: "jeff=ey E." «mailto:[email protected]» Cc: Adriaan Tuiten Hi Jeffrey, EFTA_R1_01919501 EFTA02667640 </=iv> Just got off the call with Adriaan. Attached is the Q=9Cpitch deck" for EB. I'll try for a thr

tin, should we try to touch base on Monday? The rest of the =eek is pretty much shot for me with visitors. Best, Don > On Dec 2,=2016, at 9:32 AM, Nowak, Martin A wrote: > Don=, Jeffrey > I would like to put you in direct email contact. 3 EFTA_R1_01919685 EFTA02667792 ><=r class="m_-6698346136

things on the top=c of placebo response, which are still not that =div> 3. If interested in exploring investing in EB, I =an put you in touch with Adriaan, who lives in </=iv> Are any of these appealing? I prefer 1 to 2. I think a=face to face version of 3 could be arranged let me know. On Dec 7, 20

ts is the following. T=is morning I just had an exchange of emails with the CEO of EB, whom I4>=804,ve known and worked with for about three years, Adriaan Tuiten. =He wrote that FDA has agreed with EB's proposal for more trials, a=d the EB board of directors just approved the issuance of about 12 million=Euro

rldwide Confirm • • ' stitute 11:00am Martin Nowak Katherine is assistant. 11:30am-1:30pm Joi Ito

Meridean Aviation Janusz to DRIVE YOU 9:57am Depart NY 10:34am Arrive Bedford, Jet Aviation Tristar Worldwide Confirm • • ' stitute 11:00am Martin Nowak Katherine is assistant. 11:30am-1:30pm Joi Ito and Sultan (Yuko is Joi's assistant: I (Jim is Sultan's assistant: 12:00pm LUNCH to be served 1:

to SFO w mom 9:30am Steve Hanson 10:0am Appt w/Anthony Barrett ( 10:30am Appt tv, 11:30am Appt w, 1:00pm SKYPE Conference Call w/Don Rubin and Adriaan (Don and EFTA00285210 2:00pm Appt w/Deepak 3:00pm Appt w/James Ce (He needs a few minutes with you first before he can get started on his two h

tin, should we try to touch base on Monday? The rest of =he week is pretty much shot for me with visitors. Best, Don > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. <[email protected]> wrote: > Don , Jeffrey > I would like to put you in direct email contact. > also cc Lesley. >m please note

cts is the following. =nbsp;This morning I just had an exchange of emails with the CEO of EB, =hom I've known and worked with for about three years, Adriaan =uiten. He wrote that FDA has agreed with EB's proposal =or more trials, and the EB board of directors just approved the =ssuance of about 12 milli